{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:56:47Z","timestamp":1793224607841,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009827","name":"Alexandria University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009827","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.actatropica.2022.106342","type":"journal-article","created":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T02:13:04Z","timestamp":1644631984000},"page":"106342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["A single oral dose of celecoxib-loaded solid lipid nanoparticles for treatment of different developmental stages of experimental schistosomiasis mansoni"],"prefix":"10.1016","volume":"229","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4066-4189","authenticated-orcid":false,"given":"Eman Ibrahim","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1095-7263","authenticated-orcid":false,"given":"Iman Fathy","family":"Abou-El-Naga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona Mohamed","family":"El-Temsahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman Sheta Ali","family":"Elsawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaimaa","family":"Makled","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nermine Mogahed Fawzy Hussein","family":"Mogahed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actatropica.2022.106342_bib0001","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.apjtm.2015.10.015","article-title":"Demographic, socioeconomic and environmental changes affecting circulation of neglected tropical diseases in Egypt","volume":"8","author":"Abou-El-Naga","year":"2015","journal-title":"Asian Pac. J. Trop. Med."},{"key":"10.1016\/j.actatropica.2022.106342_bib0002","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.actatropica.2018.02.005","article-title":"Towards elimination of schistosomiasis after 5000 years of endemicity in Egypt","volume":"181","author":"Abou-El-Naga","year":"2018","journal-title":"Acta Trop."},{"key":"10.1016\/j.actatropica.2022.106342_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.cimid.2019.101341","article-title":"Biological and proteomic studies of Schistosoma mansoni with decreased sensitivity to praziquantel","volume":"66","author":"Abou-El-Naga","year":"2019","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.actatropica.2022.106342_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2021.105891","article-title":"Effect of celecoxib against different developmental stages of experimental Schistosoma mansoni infection","author":"Abou-El-Naga","year":"2021","journal-title":"Acta Trop."},{"key":"10.1016\/j.actatropica.2022.106342_bib0005","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.parint.2017.08.007","article-title":"The effect of lopinavir\/ritonavir and lopinavir\/ritonavir loaded PLGA nanoparticles on experimental toxoplasmosis","volume":"66","author":"Abou-El-Naga","year":"2017","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.actatropica.2022.106342_bib0006","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1590\/0074-02760150016","article-title":"Impact of the age of Biomphalaria alexandrina snails on Schistosoma mansoni transmission: modulation of the genetic outcome and the internal defence system of the snail","volume":"110","author":"Abou-El-Naga","year":"2015","journal-title":"Mem\u00f3rias Inst. Oswaldo Cruz"},{"issue":"1","key":"10.1016\/j.actatropica.2022.106342_bib0007","doi-asserted-by":"crossref","DOI":"10.7705\/biomedica.5913","article-title":"Praziquantel-encapsulated niosomes against Schistosoma mansoni with reduced sensitivity to praziquantel","volume":"42","author":"Amer","year":"2022","journal-title":"Biom\u00e9dica"},{"key":"10.1016\/j.actatropica.2022.106342_bib0008","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1590\/S0074-02762010000400013","article-title":"Angiogenesis and schistosomiasis","volume":"105","author":"Andrade","year":"2010","journal-title":"Mem\u00f3rias Inst. Oswaldo Cruz"},{"key":"10.1016\/j.actatropica.2022.106342_bib0009","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2174\/1871526519666181231153139","article-title":"PZQ therapy: how close are we in the development of effective alternative anti-schistosomal drugs?","volume":"19","author":"Aruleba","year":"2019","journal-title":"Infect. Disord. Drug Targets"},{"key":"10.1016\/j.actatropica.2022.106342_bib0010","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejpb.2016.10.024","article-title":"Evading P-glycoprotein mediated-efflux chemoresistance using solid lipid nanoparticles","volume":"110","author":"Cavaco","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.actatropica.2022.106342_bib0011","first-page":"328","article-title":"Conditions affecting the accuracy of potassium hydroxide digestion techniques for counting Schistosoma mansoni eggs in tissues","volume":"39","author":"Cheever","year":"1968","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.actatropica.2022.106342_bib0013","first-page":"7467","article-title":"Antioxidant and hepatoprotective role of gold nanoparticles against murine hepatic schistosomiasis","volume":"10","author":"Dkhil","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.actatropica.2022.106342_bib0014","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.sjbs.2016.12.017","article-title":"Effect of gold nanoparticles on mice splenomegaly induced by schistosomiasis mansoni","volume":"6","author":"Dkhil","year":"2017","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.actatropica.2022.106342_bib0015","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.sjbs.2018.02.008","article-title":"Evaluation of nanoselenium and nanogold activities against murine intestinal schistosomiasis","volume":"7","author":"Dkhil","year":"2019","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.actatropica.2022.106342_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2021.102352","article-title":"Preparation, characterization and in vivo pharmacokinetic evaluation of curcuminoids-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs)","author":"Dolatabadi","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.actatropica.2022.106342_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141788","article-title":"Miltefosine lipid nanocapsules for single dose oral treatment of schistosomiasis mansoni: a preclinical study","volume":"10","author":"Eissa","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.actatropica.2022.106342_bib0018","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4314\/tjpr.v14i2.3","article-title":"Characterization of celecoxib-loaded solid lipid nanoparticles formulated with tristearin and softisan 100","volume":"14","author":"Fouad","year":"2015","journal-title":"Trop. J. Pharm. Res."},{"key":"10.1016\/j.actatropica.2022.106342_bib0019","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.msec.2016.05.119","article-title":"Solid lipid nanoparticles as attractive drug vehicles: composition, properties and therapeutic strategies","volume":"68","author":"Geszke-Moritz","year":"2016","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.actatropica.2022.106342_bib0020","first-page":"1848","article-title":"Solid lipid nanoparticles for oral delivery of poorly soluble drugs","volume":"4","author":"Jawahar","year":"2012","journal-title":"J. Pharm. Sci. Res."},{"key":"10.1016\/j.actatropica.2022.106342_bib0022","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.molbiopara.2010.05.003","article-title":"Schistosoma mansoni express higher levels of multidrug resistance-associated protein 1 (SmMRP1) in juvenile worms and in response to praziquantel","volume":"173","author":"Kasinathan","year":"2010","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.actatropica.2022.106342_bib0023","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ebiom.2019.04.029","article-title":"Phenotypic screening of nonsteroidal anti-inflammatory drugs identified mefenamic acid as a drug for the treatment of schistosomiasis","volume":"43","author":"Lago","year":"2019","journal-title":"EBioMedicine"},{"issue":"1\u20132","key":"10.1016\/j.actatropica.2022.106342_bib0024","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ijpharm.2016.12.026","article-title":"Nebulized solid lipid nanoparticles for the potential treatment of pulmonary hypertension via targeted delivery of phosphodiesterase-5- inhibitor","volume":"517","author":"Makled","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actatropica.2022.106342_bib0025","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1358\/mf.2005.27.2.876286","article-title":"Solid lipid nanoparticles as drug delivery systems","volume":"27","author":"Manjunath","year":"2005","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.actatropica.2022.106342_bib0026","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0169-409X(01)00105-3","article-title":"Solid lipid nanoparticles: production, characterization and applications","volume":"47","author":"Mehnert","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actatropica.2022.106342_bib0027","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.molbiopara.2009.04.007","article-title":"Schistosoma mansoni P-glycoprotein levels increase in response to praziquantel exposure and correlate with reduced praziquantel susceptibility","volume":"167","author":"Messerli","year":"2009","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.actatropica.2022.106342_bib0028","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s13346-012-0088-9","article-title":"Engineering solid lipid nanoparticles for improved drug delivery: promises and challenges of translational research","volume":"2","author":"Mishra","year":"2012","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.actatropica.2022.106342_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111103","article-title":"Lipid-based nanocarrier-mediated targeted delivery of celecoxib attenuate severity of ulcerative colitis","volume":"116","author":"Mishra","year":"2020","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.actatropica.2022.106342_bib0030","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1080\/03639040802130061","article-title":"Lipid nanoparticles with a solid matrix (SLN, NLC, LDC) for oral drug delivery","volume":"34","author":"Muchow","year":"2008","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.actatropica.2022.106342_bib0031","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4103\/0250-474X.57282","article-title":"Solid lipid nanoparticles: a modern formulation approach in drug delivery system","volume":"71","author":"Mukherjee","year":"2009","journal-title":"Indian J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.actatropica.2022.106342_bib0032","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/157016312799304552","article-title":"Preparation and characterization of solid lipid nanoparticles-a review","volume":"9","author":"Parhi","year":"2012","journal-title":"Curr. Drug Discov. Technol."},{"key":"10.1016\/j.actatropica.2022.106342_bib0033","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.colsurfb.2019.05.061","article-title":"Enhanced storage stability of solid lipid nanoparticles by surface modification of comb-shaped amphiphilic inulin derivatives","volume":"181","author":"Peng","year":"2019","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.actatropica.2022.106342_bib0034","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2174\/138920012800166526","article-title":"Absorption, disposition and pharmacokinetics of solid lipid nanoparticles","volume":"13","author":"Qi","year":"2012","journal-title":"Curr. Drug Metab."},{"issue":"1","key":"10.1016\/j.actatropica.2022.106342_bib0035","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s13071-019-3563-z","article-title":"A novel praziquantel solid lipid nanoparticle formulation shows enhanced bioavailability and antischistosomal efficacy against murine S. mansoni infection","volume":"12","author":"Radwan","year":"2019","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.actatropica.2022.106342_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2019.106379","article-title":"A journey of celecoxib from pain to cancer","volume":"147","author":"Saxena","year":"2020","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.actatropica.2022.106342_bib0037","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.587997","article-title":"Solid lipid nanoparticles for drug delivery: pharmacological and biopharmaceutical aspects","volume":"7","author":"Scioli Montoto","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.actatropica.2022.106342_bib0038","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1017\/S0031182000086248","article-title":"The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of the adult worms","volume":"55","author":"Smithers","year":"1965","journal-title":"Parasitology"},{"key":"10.1016\/j.actatropica.2022.106342_bib0039","doi-asserted-by":"crossref","first-page":"12320","DOI":"10.1002\/anie.201403036","article-title":"Engineered nanoparticles for drug delivery in cancer therapy","volume":"53","author":"Sun","year":"2014","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.actatropica.2022.106342_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2019.109874","article-title":"Design of colloidal drug carriers of celecoxib for use in treatment of breast cancer and leukemia","volume":"103","author":"\u00dcner","year":"2019","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.actatropica.2022.106342_bib0041","doi-asserted-by":"crossref","first-page":"532","DOI":"10.2174\/1573413710666140218231307","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers of celecoxib for topical application\u2013preparation, characterization and drug penetration through rat skin","volume":"10","author":"Unera","year":"2014","journal-title":"Curr. Nanosci."},{"key":"10.1016\/j.actatropica.2022.106342_bib0042","doi-asserted-by":"crossref","DOI":"10.1590\/1678-9199-jvatitd-1441-18","article-title":"Nanoparticulate drug delivery systems for the treatment of neglected tropical protozoan diseases","volume":"25","author":"Volpedo","year":"2019","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."},{"issue":"6","key":"10.1016\/j.actatropica.2022.106342_bib0043","first-page":"711","article-title":"Host response to eggs of S. mansoni. I. Granuloma formation in the unsensitized laboratory mouse","volume":"41","author":"Von","year":"1962","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.actatropica.2022.106342_bib0044","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.2174\/1389450115666140804124808","article-title":"Safety of nanoparticles in medicine","volume":"16","author":"Wolfram","year":"2015","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.actatropica.2022.106342_bib0046","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.colsurfb.2007.06.011","article-title":"Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification","volume":"60","author":"Yuan","year":"2007","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.actatropica.2022.106342_bib0047","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0939-6411(97)00150-1","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery\u2013drug release and release mechanism","volume":"45","author":"zur M\u00fchlen","year":"1998","journal-title":"Eur. J. Pharm. Biopharm."}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X22000419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X22000419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T09:24:55Z","timestamp":1762075495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X22000419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":44,"alternative-id":["S0001706X22000419"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2022.106342","relation":{},"ISSN":["0001-706X"],"issn-type":[{"value":"0001-706X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A single oral dose of celecoxib-loaded solid lipid nanoparticles for treatment of different developmental stages of experimental schistosomiasis mansoni","name":"articletitle","label":"Article Title"},{"value":"Acta Tropica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actatropica.2022.106342","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106342"}}